Trial reportEuropean journal of nutrition2025
Daily profiles of plasma short-chain fatty acids after the intake of three different cereal fibers: a randomized controlled study.
Trial report in European journal of nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05443828 (Short-chain Fatty Acids in Plasma After Intake of Fermentable Cereal Fibres- An Extended Postprandial Study), which is not on this map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Short-chain Fatty Acids in Plasma After Intake of Fermentable Cereal Fibres- An Extended Postprandial Study
Who cites it
3 citing papers in PubMed.
- Improving Oxidative Stress Through a Wheat Aleurone-Rich Diet: Are Short-Chain Fatty Acids Possible Mediators?Nutrients · 2025Trial
- The Gut-Pancreas Axis in Type 1 Diabetes: Emerging Insights into Microbiota and Immune Interactions.International journal of molecular sciences · 2026Review
- The role and mechanisms of gut microbiota in blood pressure regulation and cardiovascular health in hypertensive patients: an intervention study based on probiotics and high-fiber diets.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeTo evaluate plasma short-chain fatty acids (SCFA) profiles after the acute intake of cereal fibers in overweight individuals.
methodsIn a randomized, controlled cross-over study, twenty overweight/obese individuals, 30-75 years, consumed at one-week interval three products, each containing 11 g fiber (arabinoxylan (AX), wheat bran or cellulose) during a standard breakfast meal. Plasma samples were collected at fasting, for 8-h after breakfast and on the following morning. SCFAs were measured by LC-MS/MS.
resultsPlasma acetate, propionate and butyrate increased after the three test fibers (p = 0.0001, time effect). The acetate peak was observed between 300 and 360 min after all test fibers (p < 0.05-0.003). Propionate increased significantly by 60 min after AX (p = 0.017) and wheat bran (p = 0.036) while butyrate increased only after AX (p = 0.038). A second peak was observed for propionate at 390 min after AX (p = 0.065) and wheat bran (p = 0.037) and for butyrate only after wheat bran (p = 0.024), remaining above baseline until the morning after. No significant difference was observed between the average daily plasma concentrations of acetate, propionate and butyrate. A very high inter- and intra-subjects' variability of SCFA response was observed. Cluster analysis identified high and low SCFA producers after fiber ingestion among the study participants.
conclusionsAfter fiber ingestion plasma kinetics of acetate differ from those of butyrate and propionate. Among the tested fibers, AX and wheat bran show a better intestinal fermentation ability than cellulose. Heterogeneity in the fermentation ability exists among study participants, with half of them having a minimal SCFA increase after fiber ingestion. CLINICAL TRIAL REGISTRY NUMBER: NCT05443828; https://classic. CLINICALTRIALS: gov/ct2/show/NCT05443828.
Indexed as
Identifiers
40498116What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.